Get the Stockscreener App
21.29
1.63%
0.33
Innoviva Inc stock is traded at $21.29, with a volume of 84,602.
It is up +1.63% in the last 24 hours and up +20.28% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$20.96
Open:
$20.96
24h Volume:
84,602
Relative Volume:
0.11
Market Cap:
$1.59B
Revenue:
$384.03M
Net Income/Loss:
$38.65M
P/E Ratio:
68.68
EPS:
0.31
Net Cash Flow:
$196.35M
1W Performance:
-3.04%
1M Performance:
+20.28%
6M Performance:
+12.30%
1Y Performance:
+11.24%
1-Day Range:
$20.96
$21.49
1-Week Range:
$20.68
$22.48
52-Week Range:
$16.52
$22.76
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
21.33 | 1.57B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
431.35 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
767.53 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.62 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
905.13 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.94 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
How robust is Innoviva Inc. (HVE) stock financial positionJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Will Innoviva Inc. (HVE) stock outperform small cap peers2025 Volatility Report & Weekly High Conviction Trade Ideas - newser.com
Will Innoviva Inc. (HVE) stock draw ESG focused fundsJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com
How buybacks impact Innoviva Inc. stock valueBond Market & Fast Entry and Exit Trade Plans - newser.com
How Innoviva Inc. (HVE) stock trades after rate cuts2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
How institutional ownership impacts Innoviva Inc. stock2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - newser.com
FDA Verdict Looms: Is Zoliflodacin Poised To Transform Gonorrhea Treatment? - RTTNews
Using data filters to optimize entry into Innoviva Inc.Portfolio Gains Summary & Real-Time Market Trend Scan - newser.com
Will Innoviva Inc. stock deliver better than expected guidanceJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Is Innoviva Inc. (HVE) stock resilient in recession scenariosWeekly Trade Analysis & Low Risk High Reward Trade Ideas - newser.com
Innoviva Inc. stock outlook for YEARBear Alert & Fast Moving Stock Trade Plans - newser.com
What is the fair value estimate for Innoviva Inc. (HVE) stock in 2025Trade Signal Summary & High Win Rate Trade Tips - newser.com
Innoviva Inc. recovery potential after sell offPortfolio Risk Summary & Growth Focused Stock Reports - newser.com
Is Innoviva Inc. still worth holding after the dipJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
What sentiment indicators say about Innoviva Inc. stockVolume Spike & Weekly Chart Analysis and Trade Guides - newser.com
What technical models suggest about Innoviva Inc.’s comebackWeekly Profit Summary & Weekly Momentum Picks - newser.com
Is Innoviva Inc. (HVE) stock at risk of policy regulationInflation Watch & Expert Approved Trade Ideas - newser.com
Why institutional investors increase stakes in Innoviva Inc. (HVE) stockEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com
How Innoviva Inc. stock reacts to Fed rate cutsPortfolio Growth Summary & Long-Term Growth Portfolio Plans - newser.com
Price-Driven Insight from (INVA) for Rule-Based Strategy - news.stocktradersdaily.com
How Innoviva Inc. (HVE) stock reacts to stronger dollarTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Innoviva Inc Stock (INVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
0.28%
2.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):